Rep. Manning Introduces Legislation to Expand Transparency in Pharmaceutical Industry
March 16, 2022
March 16, 2022
WASHINGTON, March 16 -- Rep. Kathy Manning, D-North Carolina, issued the following news release:
Congresswoman Kathy Manning (NC-06) introduced new legislation to increase transparency in the pharmaceutical industry and ensure that the Food and Drug Administration (FDA) can monitor the availability of medications, preventing shortages and driving competition.
The Biologics Transparency Act of 2022 (https://www.congress.gov/bill/117th-congress/house-bill/7035), H.R. 7035 . . .
Congresswoman Kathy Manning (NC-06) introduced new legislation to increase transparency in the pharmaceutical industry and ensure that the Food and Drug Administration (FDA) can monitor the availability of medications, preventing shortages and driving competition.
The Biologics Transparency Act of 2022 (https://www.congress.gov/bill/117th-congress/house-bill/7035), H.R. 7035 . . .